HomeNews & Events/Media Coverage

Media Coverage

2024-07-22

New Blood in Biotech: G-SURE to List on Emerging Stock Board July 25, Eyeing the New Blue Ocean of Nuclear Medicine. ― SETN News

PET Pharm Biotech (G-SURE, 7762-TW), Taiwan's first radiopharmaceutical company to be dual-certified by the Ministry of Health and Welfare (MOHW) and the Nuclear Safety Commission (NSC), is scheduled to list on the Emerging Stock Board on July 25.

2024-04-21

Nuclear Medicine and M&A Synergies Fuel High Growth for G-SURE This Year. ― Commercial Times

GM Liang-Kuang Lin noted that growth in nuclear medicine is fueled by aging demographics, the proliferation of PET scans, and the emerging "Theranostics" trend.